Table 1 Demographics of patients with and without PPI use after propensity score matching.
From: Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
PPI user | PPI non-user | P value | |
|---|---|---|---|
Mean ± SD/(N,%) | Mean ± SD/(N,%) | ||
Case no | 44,341 | 177,364 | |
Gender | |||
Female (N,%) | 18,979 (42.80%) | 75,916 (42.80%) | 1.000 |
Male (N,%) | 25,362 (57.20%) | 101,448 (57.20%) | |
Age (Mean ± SD) | 59.23 (± 12.56) | 58.95 (± 12.71) | < 0.001 |
Age category (N,%) | |||
50–59 | 5679 (12.81%) | 22,716 (12.81%) | 1.000 |
60–69 | 11,672 (26.32%) | 46,688 (26.32%) | |
70–79 | 11,853 (26.73%) | 47,412 (26.73%) | |
> 80 | 15,137 (34.14%) | 60,548 (34.14%) | |
Insurance premium (NTD/month) | 16,536 (± 19,082) | 16,313 (± 18,831) | 0.028 |
Insurance premium category | |||
Dependent | 11,942 (26.93%) | 49,355 (27.83%) | 0.002 |
< 20,000 | 17,492 (39.45%) | 68,832 (38.81%) | |
20,000–39,999 | 10,148 (22.89%) | 40,173 (22.65%) | |
> 40,000 | 4759 (10.73%) | 19,004 (10.71%) | |
CCI score | 1.67 (± 1.62) | 1.32 (± 1.44) | < 0.001 |
CCI score category | |||
0 | 11,012 (24.83%) | 56,851 (32.05%) | < 0.001 |
1 | 13,325 (30.05%) | 60,563 (34.15%) | |
2 | 9684 (21.84%) | 32,160 (18.13%) | |
3+ | 10,320 (23.27%) | 27,790 (15.67%) | |
